Hypertension: Dilatrend is indicated primarily for the management of essential hypertension: It can be used alone or in combination with other antihypertensive agents (eg, calcium-channel blockers, diuretics).
Coronary Heart Disease: Carvedilol has demonstrated clinical efficacy in coronary heart disease. Preliminary data shows efficacy and safety in patients with unstable angina and silent myocardial ischemia.
Chronic Heart Failure: Unless a contraindication exists, carvedilol is indicated for the treatment of all patients with stable and symptomatic, mild, moderate and severe chronic heart failure of ischemic or non-ischemic etiology in combination with standard therapy (including ACE inhibitors and diuretics with or without digitalis).
Left ventricular dysfunction following acute myocardial infarction. Long-term treatment following myocardial infarction complicated by left ventricular dysfunction [left ventricular ejection fraction (LVEF) ≤40% or wall motion index ≤1.3], in combination with ACE inhibitors and other treatments recommended in the management of patients after myocardial infarction.